Dr Patrick J Rose, MD | |
1001 Cardwell St, Saint Clair, MO 63077-1094 | |
(636) 629-3300 | |
(636) 629-7377 |
Full Name | Dr Patrick J Rose |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 14 Years |
Location | 1001 Cardwell St, Saint Clair, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811208341 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 2010019797 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Inspire Home Health Llc | Pilot knob, MO | Home health agency |
Mercy Hospital St Louis | Saint louis, MO | Hospital |
Mercy Hospital Washington | Washington, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mercy Clinic East Communities | 7214827922 | 491 |
News Archive
Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per share. The underwriters have the option to purchase up to an additional 1.02 million shares to cover over-allotments, if any.
BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.
The brain encodes information about our relationships and the relationships between our friends using areas involved in spatial processing, according to new research published in JNeurosci.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for SilenorĀ® (doxepin) for the treatment of insomnia.
› Verified 2 days ago
Entity Name | Mercy Clinic East Communities |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073739041 PECOS PAC ID: 7214827922 Enrollment ID: O20070521000058 |
News Archive
Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per share. The underwriters have the option to purchase up to an additional 1.02 million shares to cover over-allotments, if any.
BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.
The brain encodes information about our relationships and the relationships between our friends using areas involved in spatial processing, according to new research published in JNeurosci.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for SilenorĀ® (doxepin) for the treatment of insomnia.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Patrick J Rose, MD 1001 Cardwell St, Saint Clair, MO 63077-1094 Ph: (636) 629-3300 | Dr Patrick J Rose, MD 1001 Cardwell St, Saint Clair, MO 63077-1094 Ph: (636) 629-3300 |
News Archive
Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per share. The underwriters have the option to purchase up to an additional 1.02 million shares to cover over-allotments, if any.
BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.
The brain encodes information about our relationships and the relationships between our friends using areas involved in spatial processing, according to new research published in JNeurosci.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for SilenorĀ® (doxepin) for the treatment of insomnia.
› Verified 2 days ago
Dr. Patrick Raymond Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Cardwell St, Saint Clair, MO 63077 Phone: 636-629-3300 Fax: 636-629-7377 | |
Rebekah Suezann Helmig, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Cardwell St, Saint Clair, MO 63077 Phone: 636-629-3300 Fax: 636-629-7377 |